BUSINESS● LOWAug 6 · Aug 6, 2026, 12:05 PM
Corbus Pharmaceuticals GAAP EPS of -$1.81
Seeking Alpha Tech
Corbus Pharmaceuticals reported its GAAP Earnings Per Share (EPS) as -$1.81. This provides an update on the company's financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS34m agoMercantile Bank Non-GAAP EPS of $1.42 beats by $0.07, revenue of $73.2M beats by $2.36MSeeking Alpha TechBUSINESS37m agoMaersk, Hateco sign deal for $3.5B rail terminal network in northern VietnamSeeking Alpha Tech